UnitedHealth Group Incorporated (NYSE:UNH) Shares Sold by Clearstead Trust LLC

Clearstead Trust LLC trimmed its position in shares of UnitedHealth Group Incorporated (NYSE:UNH) by 2.9% in the second quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The firm owned 11,524 shares of the healthcare conglomerate’s stock after selling 349 shares during the period. UnitedHealth Group accounts for approximately 1.5% of Clearstead Trust LLC’s holdings, making the stock its 13th biggest position. Clearstead Trust LLC’s holdings in UnitedHealth Group were worth $5,869,000 at the end of the most recent quarter.

Other hedge funds and other institutional investors have also made changes to their positions in the company. Bell Investment Advisors Inc increased its position in shares of UnitedHealth Group by 4.8% during the 4th quarter. Bell Investment Advisors Inc now owns 525 shares of the healthcare conglomerate’s stock valued at $276,000 after purchasing an additional 24 shares during the period. Harbor Investment Advisory LLC raised its position in UnitedHealth Group by 3.2% in the first quarter. Harbor Investment Advisory LLC now owns 35,946 shares of the healthcare conglomerate’s stock worth $17,783,000 after acquiring an additional 1,129 shares in the last quarter. Austin Private Wealth LLC boosted its position in shares of UnitedHealth Group by 9.8% during the 1st quarter. Austin Private Wealth LLC now owns 1,246 shares of the healthcare conglomerate’s stock valued at $573,000 after purchasing an additional 111 shares in the last quarter. Capital Insight Partners LLC lifted its stake in UnitedHealth Group by 3.8% during the first quarter. Capital Insight Partners LLC now owns 9,045 shares of the healthcare conglomerate’s stock valued at $4,475,000 after purchasing an additional 332 shares during the last quarter. Finally, Collective Family Office LLC grew its position in UnitedHealth Group by 4.3% in the first quarter. Collective Family Office LLC now owns 1,577 shares of the healthcare conglomerate’s stock worth $780,000 after buying an additional 65 shares during the last quarter. 87.86% of the stock is currently owned by institutional investors and hedge funds.

UnitedHealth Group Price Performance

Shares of NYSE:UNH opened at $589.16 on Tuesday. The business has a 50-day moving average of $571.08 and a two-hundred day moving average of $518.38. The company has a debt-to-equity ratio of 0.67, a current ratio of 0.88 and a quick ratio of 0.88. UnitedHealth Group Incorporated has a fifty-two week low of $436.38 and a fifty-two week high of $607.94. The stock has a market capitalization of $542.25 billion, a P/E ratio of 36.01, a P/E/G ratio of 1.64 and a beta of 0.58.

UnitedHealth Group (NYSE:UNH) last released its quarterly earnings results on Tuesday, July 16th. The healthcare conglomerate reported $6.80 EPS for the quarter, beating analysts’ consensus estimates of $6.66 by $0.14. The company had revenue of $98.86 billion for the quarter, compared to analyst estimates of $98.73 billion. UnitedHealth Group had a net margin of 3.66% and a return on equity of 26.55%. The company’s quarterly revenue was up 6.4% compared to the same quarter last year. During the same quarter last year, the firm posted $6.14 earnings per share. On average, equities research analysts predict that UnitedHealth Group Incorporated will post 27.69 EPS for the current fiscal year.

UnitedHealth Group Announces Dividend

The firm also recently announced a quarterly dividend, which will be paid on Tuesday, September 24th. Shareholders of record on Monday, September 16th will be issued a $2.10 dividend. This represents a $8.40 dividend on an annualized basis and a yield of 1.43%. The ex-dividend date is Monday, September 16th. UnitedHealth Group’s dividend payout ratio (DPR) is currently 51.34%.

Insider Transactions at UnitedHealth Group

In related news, CAO Thomas E. Roos sold 2,851 shares of the business’s stock in a transaction on Wednesday, July 17th. The shares were sold at an average price of $569.88, for a total transaction of $1,624,727.88. Following the transaction, the chief accounting officer now owns 29,501 shares of the company’s stock, valued at $16,812,029.88. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available at this hyperlink. In other news, CAO Thomas E. Roos sold 2,851 shares of the company’s stock in a transaction dated Wednesday, July 17th. The shares were sold at an average price of $569.88, for a total transaction of $1,624,727.88. Following the completion of the transaction, the chief accounting officer now owns 29,501 shares of the company’s stock, valued at $16,812,029.88. The sale was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this link. Also, EVP Erin Mcsweeney sold 1,500 shares of the business’s stock in a transaction dated Thursday, July 18th. The shares were sold at an average price of $579.03, for a total value of $868,545.00. Following the transaction, the executive vice president now owns 7,785 shares in the company, valued at $4,507,748.55. The disclosure for this sale can be found here. Corporate insiders own 0.33% of the company’s stock.

Wall Street Analyst Weigh In

Several equities research analysts have recently weighed in on the company. JPMorgan Chase & Co. raised their price objective on UnitedHealth Group from $546.00 to $559.00 and gave the stock an “overweight” rating in a research note on Thursday, May 30th. Jefferies Financial Group raised shares of UnitedHealth Group from a “hold” rating to a “buy” rating and upped their price objective for the company from $481.00 to $647.00 in a research note on Wednesday, July 17th. Argus boosted their price target on shares of UnitedHealth Group from $570.00 to $600.00 and gave the company a “buy” rating in a report on Wednesday, July 17th. Wells Fargo & Company raised their price objective on UnitedHealth Group from $525.00 to $630.00 and gave the stock an “overweight” rating in a research report on Wednesday, July 17th. Finally, UBS Group increased their price target on shares of UnitedHealth Group from $640.00 to $680.00 and gave the stock a “buy” rating in a research report on Thursday, July 18th. One investment analyst has rated the stock with a hold rating, nineteen have assigned a buy rating and one has assigned a strong buy rating to the company. According to MarketBeat.com, the stock has a consensus rating of “Buy” and an average target price of $614.17.

UnitedHealth Group Profile

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.